Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05834660 · ClinicalTrials.gov registry record · NA
SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools
A NA study of Suicidal Ideation, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 347
- Enrollment target
- 1
- Study location
NCT05834660: Recruiting NA study of Suicidal Ideation, sponsored by University of California, Los Angeles.
NCT05834660 is a NA study of Suicidal Ideation that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 347 participants, above the 264-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (31% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05834660, a NA study of Suicidal Ideation, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 347 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will adapt Safe Alternatives For Teens and Youth - Acute (SAFETY-A) for implementation in low-resourced school districts to reduce racial/ethnic disparities in mental health service use (MHS) following identification of suicide risk in youth. SAFETY-A will be adapted to fit the organizational context of school districts and to reduce mistrust of MHS, internalized stigma, and concealment of youth emotional distress that arise in school suicide risk assessments with Asian American and Latinx students. Following a prototyping case series, a feasibility trial will assign four districts to the timing of SAFETY-A implementation to generate preliminary data on feasibility and impacts on proposed mechanisms and youth MHS utilization and clinical outcomes across racial/ethnic groups.
Conditions Studied
Interventions
- BEHAVIORAL Safe Alternatives for Teens and Youth-Acute for Schools (SAFETY-A for Schools)
Study Locations (1)
California
- University of California Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2025-08 |
| Phase | NA |
What NCT05834660 shows while recruiting
NCT05834660 is an interventional study that assigns participants to a tested intervention. The registered 347 participants enrollment target is mid-sized for trials with a published cap, above the 264-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (31% higher).
The record links to 1 condition, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Safe Alternatives for Teens and Youth-Acute for Schools (SAFETY-A for Schools) is the first listed.
NCT05834660 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05834660 about?
NCT05834660 is a clinical study titled "SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools". This study will adapt Safe Alternatives For Teens and Youth - Acute (SAFETY-A) for implementation in low-resourced school districts to reduce racial/ethnic disparities in mental health service use (MHS) following identification of suicide risk in youth. SAFETY-A will be adapted to fit the organizati...
What is the current status of trial NCT05834660?
This trial is currently recruiting. It is a NA study. The enrollment target is 347 participants. The study started on 2022-11-01. Estimated completion is 2025-08.
What conditions does trial NCT05834660 study?
This clinical trial studies the following conditions: Suicidal Ideation.
What interventions are being tested in trial NCT05834660?
The interventions under investigation include: Safe Alternatives for Teens and Youth-Acute for Schools (SAFETY-A for Schools) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05834660?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05834660 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05834660's enrollment target sits among peer trials
347 15th of 84 higher than 70 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- NCT04877522 · 347 participants · Phase 4
Asciminib Roll-over Study
- NCT06963827 · 347 participants · Phase 3
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
- NCT04041479 · 348 participants · Phase 3
Biomarker-guided rTMS for Treatment Resistant Depression
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI